Skip to main content

Investment Year:2022
Transaction Value:N/A


In October 2022, BC XI acquired Havea, the leading European natural healthcare player.

Founded in 1975 and formerly Ponroy Santé, Havea is a France-based leading European natural healthcare group. The Company operates five strategic brands focused on natural healthcare with diversified positioning and patient profiles: Vitavea (everyday food supplements), Aragan (premium food supplements), Biolane (baby care), Dermovitamina (skin care) and Densmore (ophthalmology and gynaecology). The business has a history of consistently delivering above-market organic growth as a result of end-to-end coverage of the value chain from product development to distribution, an omnichannel approach and a unique activation strategy relying on both sell-in and sell-out levers. Havea currently employs over 800 people, and is headquartered in Boufféré, France, where it manufactures the majority of its product portfolio.

The case studies are presented herein for illustrative purposes only and should not be relied upon for investment decision making. This information is being furnished for the sole purpose of providing information about BC Partners. The specific investments identified are not representative of all of the companies purchased, sold or recommended for BC Partners' private equity funds, and it should not be assumed that investments identified were or will be profitable or are representative of investments that will be made by BC Partners in the future. Unless otherwise indicated, information with respect to the investments included herein has been obtained from the relevant portfolio company. Past performance of any BC Partners-sponsored fund, vehicle, account, or investment is not indicative of future performance. There can be no assurance that BC Partners will make comparable or equally successful investments in the future. For a list of all investments made by the private equity funds managed by BC Partners since its inception, please click here.